224 related articles for article (PubMed ID: 37307844)
1. Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study.
Zhou J; Singanayagam A; Goonawardane N; Moshe M; Sweeney FP; Sukhova K; Killingley B; Kalinova M; Mann AJ; Catchpole AP; Barer MR; Ferguson NM; Chiu C; Barclay WS
Lancet Microbe; 2023 Aug; 4(8):e579-e590. PubMed ID: 37307844
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
Killingley B; Mann AJ; Kalinova M; Boyers A; Goonawardane N; Zhou J; Lindsell K; Hare SS; Brown J; Frise R; Smith E; Hopkins C; Noulin N; Löndt B; Wilkinson T; Harden S; McShane H; Baillet M; Gilbert A; Jacobs M; Charman C; Mande P; Nguyen-Van-Tam JS; Semple MG; Read RC; Ferguson NM; Openshaw PJ; Rapeport G; Barclay WS; Catchpole AP; Chiu C
Nat Med; 2022 May; 28(5):1031-1041. PubMed ID: 35361992
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
5. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Jackson S; Marshall JL; Mawer A; Lopez-Ramon R; Harris SA; Satti I; Hughes E; Preston-Jones H; Cabrera Puig I; Longet S; Tipton T; Laidlaw S; Doherty RP; Morrison H; Mitchell R; Tanner R; Ateere A; Stylianou E; Wu MS; Fredsgaard-Jones TPW; Breuer J; Rapeport G; Ferreira VM; Gleeson F; Pollard AJ; Carroll M; Catchpole A; Chiu C; McShane H;
Lancet Microbe; 2024 Apr; ():. PubMed ID: 38703782
[TBL] [Abstract][Full Text] [Related]
7. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
[TBL] [Abstract][Full Text] [Related]
8. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
9. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
[TBL] [Abstract][Full Text] [Related]
10. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
11. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
15. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
[TBL] [Abstract][Full Text] [Related]
16. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
18. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
19. Detection of SARS-CoV-2 in Air and on Surfaces in Rooms of Infected Nursing Home Residents.
Linde KJ; Wouters IM; Kluytmans JAJW; Kluytmans-van den Bergh MFQ; Pas SD; GeurtsvanKessel CH; Koopmans MPG; Meier M; Meijer P; Raben CR; Spithoven J; Tersteeg-Zijderveld MHG; Heederik DJJ; Dohmen W;
Ann Work Expo Health; 2023 Jan; 67(1):129-140. PubMed ID: 36068657
[TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
